- Home
- AUTL vs LEU Comparison
AUTL vs LEU Comparison
Compare AUTL & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- LEU
- Stock Information
- Founded
- AUTL 2014
- LEU 1998
- Country
- AUTL United Kingdom
- LEU United States
- Employees
- AUTL N/A
- LEU N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- AUTL Health Care
- LEU Industrials
- Exchange
- AUTL Nasdaq
- LEU Nasdaq
- Market Cap
- AUTL 590.8M
- LEU 1.3B
- IPO Year
- AUTL 2018
- LEU 1998
- Fundamental
- Price
- AUTL $2.17
- LEU $79.68
- Analyst Decision
- AUTL Strong Buy
- LEU Buy
- Analyst Count
- AUTL 3
- LEU 2
- Target Price
- AUTL $10.20
- LEU $92.00
- AVG Volume (30 Days)
- AUTL 1.1M
- LEU 726.1K
- Earning Date
- AUTL 03-13-2025
- LEU 02-06-2025
- Dividend Yield
- AUTL N/A
- LEU N/A
- EPS Growth
- AUTL N/A
- LEU 50.42
- EPS
- AUTL N/A
- LEU 4.70
- Revenue
- AUTL $10,091,000.00
- LEU $394,000,000.00
- Revenue This Year
- AUTL $851.83
- LEU $25.25
- Revenue Next Year
- AUTL $224.65
- LEU $5.68
- P/E Ratio
- AUTL N/A
- LEU $17.17
- Revenue Growth
- AUTL 82.71
- LEU 14.94
- 52 Week Low
- AUTL $2.07
- LEU $33.51
- 52 Week High
- AUTL $7.37
- LEU $118.36
- Technical
- Relative Strength Index (RSI)
- AUTL 41.81
- LEU 52.43
- Support Level
- AUTL $2.11
- LEU $75.00
- Resistance Level
- AUTL $2.26
- LEU $87.46
- Average True Range (ATR)
- AUTL 0.12
- LEU 5.85
- MACD
- AUTL 0.01
- LEU 0.09
- Stochastic Oscillator
- AUTL 27.78
- LEU 42.27
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.